US20050107858A1 - Implantable electrical cable and method of making - Google Patents

Implantable electrical cable and method of making Download PDF

Info

Publication number
US20050107858A1
US20050107858A1 US11/010,370 US1037004A US2005107858A1 US 20050107858 A1 US20050107858 A1 US 20050107858A1 US 1037004 A US1037004 A US 1037004A US 2005107858 A1 US2005107858 A1 US 2005107858A1
Authority
US
United States
Prior art keywords
cable
implantable
implantable cable
fluoropolymer
film
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/010,370
Inventor
Henry Bluger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MED EL Elektromedizinische Geraete GmbH
Original Assignee
Epic Biosonics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epic Biosonics Inc filed Critical Epic Biosonics Inc
Priority to US11/010,370 priority Critical patent/US20050107858A1/en
Publication of US20050107858A1 publication Critical patent/US20050107858A1/en
Assigned to MED-EL ELEKTRO-MEDIZINISCHE GERATE GESELLSCHAFT M.B.H. reassignment MED-EL ELEKTRO-MEDIZINISCHE GERATE GESELLSCHAFT M.B.H. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: EPIC BIOSONICS INC.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01BCABLES; CONDUCTORS; INSULATORS; SELECTION OF MATERIALS FOR THEIR CONDUCTIVE, INSULATING OR DIELECTRIC PROPERTIES
    • H01B13/00Apparatus or processes specially adapted for manufacturing conductors or cables
    • H01B13/0009Apparatus or processes specially adapted for manufacturing conductors or cables for forming corrugations on conductors or cables
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01BCABLES; CONDUCTORS; INSULATORS; SELECTION OF MATERIALS FOR THEIR CONDUCTIVE, INSULATING OR DIELECTRIC PROPERTIES
    • H01B13/00Apparatus or processes specially adapted for manufacturing conductors or cables
    • H01B13/0013Apparatus or processes specially adapted for manufacturing conductors or cables for embedding wires in plastic layers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T156/00Adhesive bonding and miscellaneous chemical manufacture
    • Y10T156/10Methods of surface bonding and/or assembly therefor
    • Y10T156/1002Methods of surface bonding and/or assembly therefor with permanent bending or reshaping or surface deformation of self sustaining lamina
    • Y10T156/1007Running or continuous length work
    • Y10T156/1016Transverse corrugating
    • Y10T156/1018Subsequent to assembly of laminae

Definitions

  • the human body is a hostile environment to implanted medical devices and materials, particularly to chronically implanted electrical cables and leads.
  • implantable cardiac cables are typically coupled at their proximal ends with implanted pacemaker and pacemaker/cardioverter/defibrillator pulse generators.
  • the cables and insulation are subjected to cumulative mechanical stresses that can result in degradation of the insulation or fractures of the lead conductors with untoward effects on device performance and patient well-being.
  • the traditional tubular insulation is most commonly composed of an elastomeric material such as silicone or polyurethane.
  • elastomeric material such as silicone or polyurethane.
  • An implantable electrical cable must also be completely biocompatible, in that the exterior of the cable is preferably made of biocompatible materials which are strong and flexible enough that the constant flexure caused by movement of the patient or his organs does not cause the cable to rupture.
  • the exterior of the cable is also preferably smooth to avoid abrasion of surrounding tissue and other discomfort to the patient.
  • the cable is also preferably compliant and supple, to avoid damage to surrounding tissue by being so stiff that it resists movement as the surrounding tissues move. A stiff and inflexible cable would apply a bias force, which would resist movement of the patient, and which would cause discomfort to the patient.
  • U.S. Pat. No. 4,000,745 discloses the electrical leads for cardiac stimulators comprising an insulated electrical conductive section and a lead-in securing section including a helical member which may be screwed into the heart muscle.
  • U.S. Pat. No. 6,374,141 discloses a bioelectrical stimulus cable in which the insulated electrical lead includes at least one fibril having a coating of rigid insulating, low friction material. A coating of shock dampening elastomeric, insulating material is tightly set about the rigid, insulating, low friction material.
  • the cable includes a braided sheath encompassing a portion of the cable and increasing the tensile strength of the cable.
  • An implantable cable is preferably thin. Cables that have many wires will become stiffer as the numbers of parallel conductors increases. A cable should be readily interconnectable with other devices, that is, having a grouping or arrangement of conductors that are dimensionally controlled and predictably located for reliable fastening to other devices.
  • a still further object of the present invention is to provide an implantable cable which is encased with fluoropolymer such as FEP or PFA
  • a still further object of the invention is to provide a manufacturing process for an implantable cable which can be manufactured in a simple and reliable way.
  • a process to manufacture an implantable cable comprises the steps of: a) establishing a number of grooves on a first fluoropolymer film layer; b) positioning biocompatible wires into said grooves; c) applying heat to confine said wires into said grooves; d) deposing a second fluoropolymer layer; e) encapsulating a resulting structure by applying heat; f) undulating a further resulting structure; g) activating the surface of the fluoropolymer film layer; and h) encapsulating a final structure with silicone.
  • the first and second fluoropolymer layers are preferably comprised of FEP or PFA.
  • the conductor wire is preferably comprised of Pt or Pt/Ir.
  • the tip portion of the implantable cable may be cut away to establish lead through laser cutting.
  • the conductor wires may have a flat, round, oval or rectangular cross section.
  • FIG. 1A is a sectional view of a fluoropolymer film used to manufacture an implantable cable according to the present invention.
  • FIG. 2A is a sectional view of a fluoropolymer film within which a conductor wire is placed in each groove.
  • FIG. 2B is a sectional view of a fluoropolymer film having conductor wires after a thermal treatment.
  • FIG. 3A is a sectional view of a fluoropolymer film having conductor wires on which another fluoropolymer film is deposited.
  • FIG. 3B is a sectional view of the final structure of an implantable cable according to the present invention.
  • FIG. 4A shows one method of undulating an implantable cable according to the present invention.
  • FIG. 4B shows another method of undulating an implantable cable according to the present invention.
  • FIG. 5A is a perspective view of an undulated implantable cable according to the present invention.
  • FIG. 5B is perspective view of an undulated implantable cable with the fluoropolymer material removed from the tip.
  • FIG. 6 is a sectional view of an undulated implantable cable undergoing plasma treatment.
  • FIG. 7A shows an undulated implantable cable encapsulated with silicone.
  • FIG. 7B shows a method of encapsulating an undulated implantable cable with silicone.
  • FIG. 1A is a sectional view of a fluoropolymer film 2 used to manufacture an implantable cable according to the present invention.
  • FEP or PFA film 2 is used in the preferred embodiment of the present invention.
  • other melt processable biomaterials such as fluorocarbons PVDF, PCTFE, ECTFE, ETFE, MFA (a copolymer of TFE and PVE), polyethylene's and polypropylenes.
  • the thickness of the film 2 is preferably about 20-100 ⁇ m.
  • FIG. 1B is a sectional view of a fluoropolymer film 2 having grooves 4 to manufacture an implantable cable according to the present invention.
  • a plurality of grooves 4 are established within the FEP film 2 through laser cutting or other method such as thermal forming and sawing.
  • FIG. 2A is a sectional view of a fluoropolymer film as in FIG. 1B with a conductor wire 6 placed in each groove 4 in the FEP film 2 .
  • Conductor wire 6 may be made of Pt or a Pt/Ir alloy.
  • the conductor wires 6 may preferably have round, oval or rectangular cross sections. Instead of Pt or Pt/Ir, well known to those skilled in the art, titanium (and some alloys thereof), platinum, tantalum, or gold may be used.
  • FIG. 2B is a sectional view of a fluoropolymer film as in FIG. 2A after a thermal treatment.
  • a thermal treatment is applied to the structure.
  • FIG. 3A is a sectional view of a fluoropolymer film as in FIG. 2B on which another fluoropolymer film 8 is deposited.
  • another film 8 is deposited on the film 2 in which the conductor wires are located.
  • Film 8 is preferably FEP, but, as with film 2 , may be PFA or other melt processable biomaterials such as fluorocarbons PVDF, PCTFE, ECTFE, ETFE, MFA (a copolymer of TFE and PVE), polyethylenes and polypropylenes.
  • FIG. 3B is a sectional view of the final structure of an implantable cable according to the present invention. After depositing film 8 , another thermal treatment is applied, forming a relatively flat implantable cable 300 . The conductor wires 6 are thus tightly encapsulated within the fluoropolymer film forming implantable cable 300 .
  • FIGS. 4A and 4B show possible methods of undulating an implantable cable 300 according to the present invention.
  • the drums 10 may be used.
  • the drums 10 preferably have fine teeth 12 or other meshing projections which roll over the surface of implantable cable 300 , thereby undulating the implantable cable 300 and forming undulated cable 302 .
  • the drums 10 revolve at a certain speed and press the implantable cable 300 from both sides. This is a very efficient method of manufacturing undulated cable 302 .
  • FIG. 4B shows an alternative method of undulating an implantable cable 300 according to the present invention.
  • There are provided a number of pins 14 which revolve at a certain speed.
  • the pins 14 are positioned in a zigzag formation.
  • the implantable cable 300 is undulated, forming undulated cable 302 , by feeding it through the pins 14 .
  • the undulation process preferably takes place at an elevated temperature.
  • FIG. 5A is a perspective view of an undulated implantable cable 302 according to the present invention.
  • the film on the tip of the undulated implantable cable 302 is then partly cut away to expose the conductor wires 6 . While any suitable method to strip the cable tip without damaging the wires may be used, laser cutting is the preferred method.
  • the exposed wires may then be welded to either a connector or an exposed junction, in order to connect undulated implantable cable 302 to another device.
  • FIG. 6 is a sectional view of an undulated implantable cable 302 undergoing a plasma treatment. The cable is treated on both sides, as shown by the arrows. This treatment facilitates the adhesion of an encapsulating layer of silicone to the implantable cable 302 .
  • FIG. 7A shows an undulated implantable cable 302 encased with a silicone coating 16 by an injection molding method.
  • FIG. 7B shows another method in which the undulated implantable cable 302 is fed through a bottle shaped tool 20 through which liquid silicone 18 is flowing, thereby encapsulating the undulated implantable cable 302 .
  • a heat coil or some other heat source may be used to provide heat to keep the silicone 18 warm and flowable, to ensure good uniform contact and coverage over all sides of the undulated implantable cable 302 .
  • the implantable cable described herein may be manufactured using low cost technology and simple-to-implement manufacturing techniques for mass production.
  • implantable cable of the present invention may be safely and reliably used in various medical devices.

Abstract

The present invention is an implantable cable and a process to manufacture said implantable cable. The cable is composed of a biocompatible fluoropolymer, in which biocompatible conductor wires are embedded. The entire cable is heat treated at various stages to ensure the wires are securely embedded. The cable is then undulated to enhance its pliability and flexibility. Further treatment activates the outer surface of the cable, following which it may be encapsulated in silicone.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application is a Divisional of U.S. patent application Ser. No. 10/623,639, which was filed on Jul. 22, 2003.
  • TECHNICAL FIELD OF THE INVENTION
  • This present invention relates generally to the field of implantable medical cables and conductor wires, particularly to implantable medical cable for use with various implantable electrical devices such as cochlear implants and other neurostimulation and recording applications, and to a method of fabricating such cables.
  • BACKGROUND OF THE INVENTION
  • The human body is a hostile environment to implanted medical devices and materials, particularly to chronically implanted electrical cables and leads. For example, implantable cardiac cables are typically coupled at their proximal ends with implanted pacemaker and pacemaker/cardioverter/defibrillator pulse generators. Over the years of implantation, the cables and insulation are subjected to cumulative mechanical stresses that can result in degradation of the insulation or fractures of the lead conductors with untoward effects on device performance and patient well-being.
  • The traditional tubular insulation is most commonly composed of an elastomeric material such as silicone or polyurethane. The combination of a helically wound conductor with elastomeric outer insulation provides conventional construction with the potential for a substantial amount of elastic deformation in the direction of the length of the lead.
  • An implantable electrical cable must also be completely biocompatible, in that the exterior of the cable is preferably made of biocompatible materials which are strong and flexible enough that the constant flexure caused by movement of the patient or his organs does not cause the cable to rupture. The exterior of the cable is also preferably smooth to avoid abrasion of surrounding tissue and other discomfort to the patient. The cable is also preferably compliant and supple, to avoid damage to surrounding tissue by being so stiff that it resists movement as the surrounding tissues move. A stiff and inflexible cable would apply a bias force, which would resist movement of the patient, and which would cause discomfort to the patient.
  • U.S. Pat. No. 4,000,745 discloses the electrical leads for cardiac stimulators comprising an insulated electrical conductive section and a lead-in securing section including a helical member which may be screwed into the heart muscle.
  • U.S. Pat. No. 6,374,141 discloses a bioelectrical stimulus cable in which the insulated electrical lead includes at least one fibril having a coating of rigid insulating, low friction material. A coating of shock dampening elastomeric, insulating material is tightly set about the rigid, insulating, low friction material. In one preferred embodiment, the cable includes a braided sheath encompassing a portion of the cable and increasing the tensile strength of the cable.
  • Notwithstanding the variety of the implantable cable designs that have been proposed, there is still a desire to improve the mechanical characteristics and the product capability of the implantable electrical cables.
  • An implantable cable is preferably thin. Cables that have many wires will become stiffer as the numbers of parallel conductors increases. A cable should be readily interconnectable with other devices, that is, having a grouping or arrangement of conductors that are dimensionally controlled and predictably located for reliable fastening to other devices.
  • It is thus an object of the present invention to provide an implantable cable which can withstand constant flexure during long term chronic implantation.
  • A still further object of the present invention is to provide an implantable cable which is encased with fluoropolymer such as FEP or PFA
  • A further object of the present invention is to provide an implantable cable having improved mechanical characteristics and improved manufacturability.
  • A still further object of the invention is to provide a manufacturing process for an implantable cable which can be manufactured in a simple and reliable way.
  • These and other objects of the invention will be appreciated by reference to the summary of the invention and to the detailed description of the preferred embodiment that follow. It will be appreciated that all of the foregoing objectives may not be satisfied simultaneously by the preferred embodiment or by each of the claims.
  • SUMMARY OF THE INVENTION
  • In accordance with one aspect of the present invention, a process to manufacture an implantable cable comprises the steps of: a) establishing a number of grooves on a first fluoropolymer film layer; b) positioning biocompatible wires into said grooves; c) applying heat to confine said wires into said grooves; d) deposing a second fluoropolymer layer; e) encapsulating a resulting structure by applying heat; f) undulating a further resulting structure; g) activating the surface of the fluoropolymer film layer; and h) encapsulating a final structure with silicone.
  • The first and second fluoropolymer layers are preferably comprised of FEP or PFA. The conductor wire is preferably comprised of Pt or Pt/Ir. The tip portion of the implantable cable may be cut away to establish lead through laser cutting. The conductor wires may have a flat, round, oval or rectangular cross section.
  • The foregoing was intended as a broad summary only and of only some of the aspects of the invention. It was not intended to define the limits or requirements of the invention. Other aspects of the invention will be appreciated by reference to the detailed description of the preferred embodiment and to the claims.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1A is a sectional view of a fluoropolymer film used to manufacture an implantable cable according to the present invention.
  • FIG. 1B is a sectional view of a fluoropolymer film having grooves to manufacture an implantable cable according to the present invention.
  • FIG. 2A is a sectional view of a fluoropolymer film within which a conductor wire is placed in each groove.
  • FIG. 2B is a sectional view of a fluoropolymer film having conductor wires after a thermal treatment.
  • FIG. 3A is a sectional view of a fluoropolymer film having conductor wires on which another fluoropolymer film is deposited.
  • FIG. 3B is a sectional view of the final structure of an implantable cable according to the present invention.
  • FIG. 4A shows one method of undulating an implantable cable according to the present invention.
  • FIG. 4B shows another method of undulating an implantable cable according to the present invention.
  • FIG. 5A is a perspective view of an undulated implantable cable according to the present invention.
  • FIG. 5B is perspective view of an undulated implantable cable with the fluoropolymer material removed from the tip.
  • FIG. 6 is a sectional view of an undulated implantable cable undergoing plasma treatment.
  • FIG. 7A shows an undulated implantable cable encapsulated with silicone.
  • FIG. 7B shows a method of encapsulating an undulated implantable cable with silicone.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
  • The following describes the best mode presently contemplated for carrying out the invention. This description is not to be taken in a limiting sense, but is made merely for describing the general principles of the invention. The scope of the invention should be determined with reference to the claims.
  • FIG. 1A is a sectional view of a fluoropolymer film 2 used to manufacture an implantable cable according to the present invention. FEP or PFA film 2 is used in the preferred embodiment of the present invention. However, it is possible to use other melt processable biomaterials such as fluorocarbons PVDF, PCTFE, ECTFE, ETFE, MFA (a copolymer of TFE and PVE), polyethylene's and polypropylenes. The thickness of the film 2 is preferably about 20-100 μm.
  • FIG. 1B is a sectional view of a fluoropolymer film 2 having grooves 4 to manufacture an implantable cable according to the present invention. A plurality of grooves 4 are established within the FEP film 2 through laser cutting or other method such as thermal forming and sawing.
  • Grooves 4 may be used to locate the conductor wires used to deliver electrical signals. FIG. 2A is a sectional view of a fluoropolymer film as in FIG. 1B with a conductor wire 6 placed in each groove 4 in the FEP film 2. Conductor wire 6 may be made of Pt or a Pt/Ir alloy. The conductor wires 6 may preferably have round, oval or rectangular cross sections. Instead of Pt or Pt/Ir, well known to those skilled in the art, titanium (and some alloys thereof), platinum, tantalum, or gold may be used.
  • FIG. 2B is a sectional view of a fluoropolymer film as in FIG. 2A after a thermal treatment. After locating wires 6 into grooves 4 shaped on film 2, heat and pressure are applied to overall structure to confine the wires within the film 2. This thermal treatment ensures the wire conductors 6 are retained within the film 2. Usually, in the case of FEP film, a thermal treatment at 240-350° C. is applied to the structure.
  • FIG. 3A is a sectional view of a fluoropolymer film as in FIG. 2B on which another fluoropolymer film 8 is deposited. To further encapsulate the wires 6, and to ensure the wires 6 will be held tightly within the structure, another film 8 is deposited on the film 2 in which the conductor wires are located. Film 8 is preferably FEP, but, as with film 2, may be PFA or other melt processable biomaterials such as fluorocarbons PVDF, PCTFE, ECTFE, ETFE, MFA (a copolymer of TFE and PVE), polyethylenes and polypropylenes.
  • FIG. 3B is a sectional view of the final structure of an implantable cable according to the present invention. After depositing film 8, another thermal treatment is applied, forming a relatively flat implantable cable 300. The conductor wires 6 are thus tightly encapsulated within the fluoropolymer film forming implantable cable 300.
  • To increase cable flexibility and pliability, by allowing ready expansion or contraction of the cable, it is preferred that the cable 300 be undulated. FIGS. 4A and 4B show possible methods of undulating an implantable cable 300 according to the present invention. As shown in FIG. 4A, two opposing drums 10 may be used. The drums 10 preferably have fine teeth 12 or other meshing projections which roll over the surface of implantable cable 300, thereby undulating the implantable cable 300 and forming undulated cable 302. The drums 10 revolve at a certain speed and press the implantable cable 300 from both sides. This is a very efficient method of manufacturing undulated cable 302.
  • FIG. 4B shows an alternative method of undulating an implantable cable 300 according to the present invention. There are provided a number of pins 14, which revolve at a certain speed. The pins 14 are positioned in a zigzag formation. Then, the implantable cable 300 is undulated, forming undulated cable 302, by feeding it through the pins 14. The undulation process preferably takes place at an elevated temperature.
  • FIG. 5A is a perspective view of an undulated implantable cable 302 according to the present invention. As shown in FIG. 5B, the film on the tip of the undulated implantable cable 302 is then partly cut away to expose the conductor wires 6. While any suitable method to strip the cable tip without damaging the wires may be used, laser cutting is the preferred method. The exposed wires may then be welded to either a connector or an exposed junction, in order to connect undulated implantable cable 302 to another device.
  • The undulated implantable cable 302 needs additional plasma treatment or sodium treatment to be activated. FIG. 6 is a sectional view of an undulated implantable cable 302 undergoing a plasma treatment. The cable is treated on both sides, as shown by the arrows. This treatment facilitates the adhesion of an encapsulating layer of silicone to the implantable cable 302.
  • After undulating the cable, it is preferred to encapsulate the implantable cable 302 with silicone. Silicone is preferred as it is highly elastic and is therefore capable of being elongated with an elastic recovery to its initial shape. FIG. 7A shows an undulated implantable cable 302 encased with a silicone coating 16 by an injection molding method. FIG. 7B shows another method in which the undulated implantable cable 302 is fed through a bottle shaped tool 20 through which liquid silicone 18 is flowing, thereby encapsulating the undulated implantable cable 302. A heat coil or some other heat source (not shown) may be used to provide heat to keep the silicone 18 warm and flowable, to ensure good uniform contact and coverage over all sides of the undulated implantable cable 302.
  • It will be understood that in general these implantable medical cables have extremely wide application in the medical device field.
  • Moreover, as described above, it is seen that the implantable cable described herein may be manufactured using low cost technology and simple-to-implement manufacturing techniques for mass production.
  • Finally, it is seen that the implantable cable of the present invention may be safely and reliably used in various medical devices.
  • The above descriptions are intended to illustrate the preferred and alternative embodiments of the invention. For example, the process for stripping out the undulated cable can be done in the last stage after encasing the cable with silicone. It will be appreciated that modifications and adaptations to such embodiments may be practiced without departing from the scope of the invention, such scope being most properly defined by reference to this specification as a whole and to the following claims.

Claims (8)

1. An implantable cable comprising:
a plurality of conductor wires embedded within a fluoropolymer film;
said fluoropolymer film comprising outer surfaces and at least one tip;
said fluoropolymer film being overall undulated;
said fluoropolymer film being removed at a tip of said implantable cable;
2. The implantable cable of claim 1, wherein said fluoropolymer is activated.
3. The implantable cable of claim 1, wherein said fluoropolymer is activated by sodium treatment of said implantable cable.
4. The implantable cable of claim 1, wherein said fluoropolymer is activated by plasma treatment of said implantable cable.
5. The implantable cable of claim 2, 3 or 4, wherein said cable is encased with silicone after activating said fluoropolymer.
6. The implantable cable of claim 1, wherein said biocompatible film is comprised of FEP or PFA.
7. The implantable cable of claim 1, wherein said conductor wires are comprised of Pt or Pt/Ir.
8. The implantable cable of claim 7, wherein said conductor wires have round, oval or rectangular cross sections.
US11/010,370 2003-07-22 2004-12-14 Implantable electrical cable and method of making Abandoned US20050107858A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/010,370 US20050107858A1 (en) 2003-07-22 2004-12-14 Implantable electrical cable and method of making

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/623,639 US6843870B1 (en) 2003-07-22 2003-07-22 Implantable electrical cable and method of making
US11/010,370 US20050107858A1 (en) 2003-07-22 2004-12-14 Implantable electrical cable and method of making

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/623,639 Division US6843870B1 (en) 2003-07-22 2003-07-22 Implantable electrical cable and method of making

Publications (1)

Publication Number Publication Date
US20050107858A1 true US20050107858A1 (en) 2005-05-19

Family

ID=33565189

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/623,639 Expired - Lifetime US6843870B1 (en) 2003-07-22 2003-07-22 Implantable electrical cable and method of making
US11/010,370 Abandoned US20050107858A1 (en) 2003-07-22 2004-12-14 Implantable electrical cable and method of making

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/623,639 Expired - Lifetime US6843870B1 (en) 2003-07-22 2003-07-22 Implantable electrical cable and method of making

Country Status (5)

Country Link
US (2) US6843870B1 (en)
EP (1) EP1651305B1 (en)
AT (1) ATE519520T1 (en)
CA (1) CA2533215C (en)
WO (1) WO2005007235A1 (en)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070244535A1 (en) * 2006-04-18 2007-10-18 Cyberonics, Inc. Heat dissipation for a lead assembly
US20080015641A1 (en) * 2006-07-12 2008-01-17 Cyberonics, Inc. Implantable Medical Device Charge Balance Assessment
US20080183258A1 (en) * 2007-01-26 2008-07-31 Inman D Michael Electrode assembly with fibers for a medical device
US20100100151A1 (en) * 2008-10-20 2010-04-22 Terry Jr Reese S Neurostimulation with signal duration determined by a cardiac cycle
US20100192374A1 (en) * 2006-07-26 2010-08-05 Cyberonics, Inc. Multi-Electrode Assembly for an Implantable Medical Device
US20100299921A1 (en) * 2009-05-26 2010-12-02 Hall Peter C Cable Consolidation with a Laser
US7869867B2 (en) 2006-10-27 2011-01-11 Cyberonics, Inc. Implantable neurostimulator with refractory stimulation
US7869885B2 (en) 2006-04-28 2011-01-11 Cyberonics, Inc Threshold optimization for tissue stimulation therapy
US7974701B2 (en) 2007-04-27 2011-07-05 Cyberonics, Inc. Dosing limitation for an implantable medical device
US8150508B2 (en) 2006-03-29 2012-04-03 Catholic Healthcare West Vagus nerve stimulation method
US8204603B2 (en) 2008-04-25 2012-06-19 Cyberonics, Inc. Blocking exogenous action potentials by an implantable medical device
US8250745B1 (en) 2008-01-24 2012-08-28 Advanced Bionics, Llc Process for manufacturing a microcircuit cochlear electrode array
US8332052B1 (en) 2010-03-18 2012-12-11 Advanced Bionics Microcircuit cochlear electrode array and method of manufacture
US8478428B2 (en) 2010-04-23 2013-07-02 Cyberonics, Inc. Helical electrode for nerve stimulation
US8565867B2 (en) 2005-01-28 2013-10-22 Cyberonics, Inc. Changeable electrode polarity stimulation by an implantable medical device
US8868203B2 (en) 2007-10-26 2014-10-21 Cyberonics, Inc. Dynamic lead condition detection for an implantable medical device
US8942798B2 (en) 2007-10-26 2015-01-27 Cyberonics, Inc. Alternative operation mode for an implantable medical device based upon lead condition
US9314633B2 (en) 2008-01-25 2016-04-19 Cyberonics, Inc. Contingent cardio-protection for epilepsy patients
WO2018157210A1 (en) * 2017-03-02 2018-09-07 Saluda Medical Pty Limited Printed lead
US20200054229A1 (en) * 2014-10-31 2020-02-20 Board Of Regents Of The University Of Texas System Method of making a neural interface system
US10653883B2 (en) 2009-01-23 2020-05-19 Livanova Usa, Inc. Implantable medical device for providing chronic condition therapy and acute condition therapy using vagus nerve stimulation

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8131375B2 (en) * 2003-03-21 2012-03-06 Second Sight Medical Products, Inc. Trans-retinal flexible circuit electrode array
US8014878B2 (en) 2005-04-28 2011-09-06 Second Sight Medical Products, Inc. Flexible circuit electrode array
WO2006089155A2 (en) * 2005-02-16 2006-08-24 Second Sight Medical Products, Inc. Fitting of brightness in a visual prosthesis
WO2008103195A2 (en) 2005-04-28 2008-08-28 Second Sight Medical Products, Inc. Flexible circuit electrode array
US7877866B1 (en) 2005-10-26 2011-02-01 Second Sight Medical Products, Inc. Flexible circuit electrode array and method of manufacturing the same
US7546165B2 (en) * 2005-12-19 2009-06-09 Cardiac Pacemakers, Inc. Interconnections of implantable lead conductors and electrodes and reinforcement therefor
US7467016B2 (en) * 2006-01-27 2008-12-16 Cyberonics, Inc. Multipolar stimulation electrode with mating structures for gripping targeted tissue
US7914842B1 (en) 2006-02-10 2011-03-29 Second Sight Medical Products, Inc Method of manufacturing a flexible circuit electrode array
US20080051861A1 (en) * 2006-04-28 2008-02-28 Cross Thomas E Implantable medical assemblies with improved flexibility, extensibility and positionability with branched structures
US20070282410A1 (en) * 2006-04-28 2007-12-06 Cross Thomas E Jr Implantable medical lead assemblies with improved flexibility and extensibility and having a substantially two-dimensional nature
US20080046058A1 (en) * 2006-04-28 2008-02-21 Cross Thomas E Methods for customizing implantable medical lead assemblies with improved flexibility and extensibility
US20080039917A1 (en) * 2006-04-28 2008-02-14 Cross Thomas E Implantable medical leads and lead assemblies with improved flexibility and extensibility to facilitate body movements
EP2046442B1 (en) * 2006-06-21 2017-01-25 Second Sight Medical Products, Inc. Flexible circuit electrode array with at least one tack opening
US20080046059A1 (en) * 2006-08-04 2008-02-21 Zarembo Paul E Lead including a heat fused or formed lead body
US7917229B2 (en) * 2006-08-31 2011-03-29 Cardiac Pacemakers, Inc. Lead assembly including a polymer interconnect and methods related thereto
US20080269857A1 (en) * 2007-04-30 2008-10-30 Cross Thomas E Implantable medical leads and lead assemblies with flexibility, extensibility and branched structures
US7725198B2 (en) * 2007-04-30 2010-05-25 Medtronic, Inc. Implantable medical lead assemblies with delivery tether
US7996090B2 (en) * 2007-04-30 2011-08-09 Medtronic, Inc. Methods of making implantable medical leads with a non-linear shape
US20080269858A1 (en) * 2007-04-30 2008-10-30 Cross Thomas E Implantable medical leads with flexibility and extensibility, and having a substantially two-dimensional nature
US7818069B2 (en) * 2007-07-27 2010-10-19 Cyberonics, Inc. Ribbon electrode
US8494656B2 (en) * 2007-09-20 2013-07-23 Medtronic, Inc. Medical electrical leads and conductor assemblies thereof
US20090240099A1 (en) * 2008-02-29 2009-09-24 Otologics, Llc Bi-modal cochlea stimulation
US8219209B2 (en) 2008-08-15 2012-07-10 Cardiac Pacemakers, Inc. Implantable medical lead having reduced dimension tubing transition
US20100069997A1 (en) * 2008-09-16 2010-03-18 Otologics, Llc Neurostimulation apparatus
US9044588B2 (en) 2009-04-16 2015-06-02 Cochlear Limited Reference electrode apparatus and method for neurostimulation implants
CN103415317B (en) * 2011-02-17 2016-04-13 先进仿生学股份公司 Line constructs
US9333337B2 (en) * 2011-05-16 2016-05-10 Lawrence Livermore National Security, Llc Method of fabricating high-density hermetic electrical feedthroughs using insulated wire bundles
JP6306410B2 (en) * 2014-04-17 2018-04-04 日本メクトロン株式会社 Flexible printed board manufacturing method, board manufacturing jig, and board manufacturing apparatus

Citations (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3540956A (en) * 1968-04-11 1970-11-17 Gore & Ass Precise conductor cables
US4000745A (en) * 1968-08-05 1977-01-04 Goldberg Edward M Electrical leads for cardiac stimulators and related methods and means
US4310390A (en) * 1977-08-10 1982-01-12 Lockheed Corporation Protective coating process for aluminum and aluminum alloys
US4357387A (en) * 1981-08-20 1982-11-02 Subtex, Inc. Flame resistant insulating fabric compositions prepared by plasma spraying
US4630887A (en) * 1983-06-17 1986-12-23 Bicc Public Limited Company Optical fibre ribbon structure
US4819647A (en) * 1984-05-03 1989-04-11 The Regents Of The University Of California Intracochlear electrode array
US4945342A (en) * 1987-10-16 1990-07-31 Instit Straumann Electrical cable for performing stimulations and/or measurements inside a human or animal body and method of manufacturing the cable
US5049215A (en) * 1990-09-19 1991-09-17 Thomas & Betts Corporation Method of forming a high impedance electrical cable
US5304741A (en) * 1992-08-10 1994-04-19 Temp-Flex Cable, Inc. Speaker cable
US5358516A (en) * 1992-12-11 1994-10-25 W. L. Gore & Associates, Inc. Implantable electrophysiology lead and method of making
US5468314A (en) * 1993-02-26 1995-11-21 W. L. Gore & Associates, Inc. Process for making an electrical cable with expandable insulation
US5892278A (en) * 1996-05-24 1999-04-06 Dai Nippon Printingco., Ltd. Aluminum and aluminum alloy radiator for semiconductor device and process for producing the same
US5925228A (en) * 1997-01-09 1999-07-20 Sandia Corporation Electrophoretically active sol-gel processes to backfill, seal, and/or densify porous, flawed, and/or cracked coatings on electrically conductive material
US6073449A (en) * 1996-06-25 2000-06-13 Technova Inc. Thermoelectric apparatus
US6246012B1 (en) * 1999-03-24 2001-06-12 Xerox Corporation Electroplated conductive carbon fibers with adhesive
US6265691B1 (en) * 1996-11-05 2001-07-24 Intermedics Inc. Method of making implantable lead including laser wire stripping
US6358281B1 (en) * 1999-11-29 2002-03-19 Epic Biosonics Inc. Totally implantable cochlear prosthesis
US6374141B1 (en) * 1999-10-08 2002-04-16 Microhelix, Inc. Multi-lead bioelectrical stimulus cable
US6372992B1 (en) * 2000-10-05 2002-04-16 3M Innovative Properties Company Circuit protective composites
US20020147992A1 (en) * 2001-04-05 2002-10-10 Lou King Method, system and computer program product for efficient storage of data
US6517657B1 (en) * 1992-01-06 2003-02-11 Pilot Industries, Inc. Fluoropolymer composite tube and method of preparation
US20030113479A1 (en) * 2001-08-23 2003-06-19 Konica Corporation Atmospheric pressure plasma treatmet apparatus and atmospheric pressure plasma treatment method
US20050103275A1 (en) * 2003-02-07 2005-05-19 Tokyo Electron Limited Plasma processing apparatus, ring member and plasma processing method
US20050150866A1 (en) * 2002-06-27 2005-07-14 Lam Research Corporation Productivity enhancing thermal sprayed yttria-containing coating for plasma reactor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5201903A (en) * 1991-10-22 1993-04-13 Pi (Medical) Corporation Method of making a miniature multi-conductor electrical cable
US7085605B2 (en) * 2003-01-23 2006-08-01 Epic Biosonics Inc. Implantable medical assembly

Patent Citations (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3540956A (en) * 1968-04-11 1970-11-17 Gore & Ass Precise conductor cables
US4000745A (en) * 1968-08-05 1977-01-04 Goldberg Edward M Electrical leads for cardiac stimulators and related methods and means
US4310390A (en) * 1977-08-10 1982-01-12 Lockheed Corporation Protective coating process for aluminum and aluminum alloys
US4357387A (en) * 1981-08-20 1982-11-02 Subtex, Inc. Flame resistant insulating fabric compositions prepared by plasma spraying
US4630887A (en) * 1983-06-17 1986-12-23 Bicc Public Limited Company Optical fibre ribbon structure
US4819647A (en) * 1984-05-03 1989-04-11 The Regents Of The University Of California Intracochlear electrode array
US4945342A (en) * 1987-10-16 1990-07-31 Instit Straumann Electrical cable for performing stimulations and/or measurements inside a human or animal body and method of manufacturing the cable
US5049215A (en) * 1990-09-19 1991-09-17 Thomas & Betts Corporation Method of forming a high impedance electrical cable
US6517657B1 (en) * 1992-01-06 2003-02-11 Pilot Industries, Inc. Fluoropolymer composite tube and method of preparation
US5304741A (en) * 1992-08-10 1994-04-19 Temp-Flex Cable, Inc. Speaker cable
US5358516A (en) * 1992-12-11 1994-10-25 W. L. Gore & Associates, Inc. Implantable electrophysiology lead and method of making
US5468314A (en) * 1993-02-26 1995-11-21 W. L. Gore & Associates, Inc. Process for making an electrical cable with expandable insulation
US5892278A (en) * 1996-05-24 1999-04-06 Dai Nippon Printingco., Ltd. Aluminum and aluminum alloy radiator for semiconductor device and process for producing the same
US6073449A (en) * 1996-06-25 2000-06-13 Technova Inc. Thermoelectric apparatus
US6265691B1 (en) * 1996-11-05 2001-07-24 Intermedics Inc. Method of making implantable lead including laser wire stripping
US5925228A (en) * 1997-01-09 1999-07-20 Sandia Corporation Electrophoretically active sol-gel processes to backfill, seal, and/or densify porous, flawed, and/or cracked coatings on electrically conductive material
US6246012B1 (en) * 1999-03-24 2001-06-12 Xerox Corporation Electroplated conductive carbon fibers with adhesive
US6374141B1 (en) * 1999-10-08 2002-04-16 Microhelix, Inc. Multi-lead bioelectrical stimulus cable
US6358281B1 (en) * 1999-11-29 2002-03-19 Epic Biosonics Inc. Totally implantable cochlear prosthesis
US6648914B2 (en) * 1999-11-29 2003-11-18 Epic Biosonics Inc. Totally implantable cochlear prosthesis
US6372992B1 (en) * 2000-10-05 2002-04-16 3M Innovative Properties Company Circuit protective composites
US20020147992A1 (en) * 2001-04-05 2002-10-10 Lou King Method, system and computer program product for efficient storage of data
US20030113479A1 (en) * 2001-08-23 2003-06-19 Konica Corporation Atmospheric pressure plasma treatmet apparatus and atmospheric pressure plasma treatment method
US20050150866A1 (en) * 2002-06-27 2005-07-14 Lam Research Corporation Productivity enhancing thermal sprayed yttria-containing coating for plasma reactor
US20050103275A1 (en) * 2003-02-07 2005-05-19 Tokyo Electron Limited Plasma processing apparatus, ring member and plasma processing method

Cited By (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8565867B2 (en) 2005-01-28 2013-10-22 Cyberonics, Inc. Changeable electrode polarity stimulation by an implantable medical device
US9586047B2 (en) 2005-01-28 2017-03-07 Cyberonics, Inc. Contingent cardio-protection for epilepsy patients
US8150508B2 (en) 2006-03-29 2012-04-03 Catholic Healthcare West Vagus nerve stimulation method
US9108041B2 (en) 2006-03-29 2015-08-18 Dignity Health Microburst electrical stimulation of cranial nerves for the treatment of medical conditions
US8280505B2 (en) 2006-03-29 2012-10-02 Catholic Healthcare West Vagus nerve stimulation method
US9533151B2 (en) 2006-03-29 2017-01-03 Dignity Health Microburst electrical stimulation of cranial nerves for the treatment of medical conditions
US8615309B2 (en) 2006-03-29 2013-12-24 Catholic Healthcare West Microburst electrical stimulation of cranial nerves for the treatment of medical conditions
US8219188B2 (en) 2006-03-29 2012-07-10 Catholic Healthcare West Synchronization of vagus nerve stimulation with the cardiac cycle of a patient
US8738126B2 (en) 2006-03-29 2014-05-27 Catholic Healthcare West Synchronization of vagus nerve stimulation with the cardiac cycle of a patient
US9289599B2 (en) 2006-03-29 2016-03-22 Dignity Health Vagus nerve stimulation method
US8660666B2 (en) 2006-03-29 2014-02-25 Catholic Healthcare West Microburst electrical stimulation of cranial nerves for the treatment of medical conditions
US20070244535A1 (en) * 2006-04-18 2007-10-18 Cyberonics, Inc. Heat dissipation for a lead assembly
US8180462B2 (en) 2006-04-18 2012-05-15 Cyberonics, Inc. Heat dissipation for a lead assembly
US7869885B2 (en) 2006-04-28 2011-01-11 Cyberonics, Inc Threshold optimization for tissue stimulation therapy
US8478420B2 (en) 2006-07-12 2013-07-02 Cyberonics, Inc. Implantable medical device charge balance assessment
US20080015641A1 (en) * 2006-07-12 2008-01-17 Cyberonics, Inc. Implantable Medical Device Charge Balance Assessment
US20100192374A1 (en) * 2006-07-26 2010-08-05 Cyberonics, Inc. Multi-Electrode Assembly for an Implantable Medical Device
US8483846B2 (en) 2006-07-26 2013-07-09 Cyberonics, Inc. Multi-electrode assembly for an implantable medical device
US7869867B2 (en) 2006-10-27 2011-01-11 Cyberonics, Inc. Implantable neurostimulator with refractory stimulation
US8295946B2 (en) 2007-01-26 2012-10-23 Cyberonics, Inc. Electrode assembly with fibers for a medical device
US20110224767A1 (en) * 2007-01-26 2011-09-15 Cyberonics, Inc. Electrode assembly with fibers for a medical device
US7974707B2 (en) 2007-01-26 2011-07-05 Cyberonics, Inc. Electrode assembly with fibers for a medical device
US20080183258A1 (en) * 2007-01-26 2008-07-31 Inman D Michael Electrode assembly with fibers for a medical device
US8306627B2 (en) 2007-04-27 2012-11-06 Cyberonics, Inc. Dosing limitation for an implantable medical device
US7974701B2 (en) 2007-04-27 2011-07-05 Cyberonics, Inc. Dosing limitation for an implantable medical device
US8868203B2 (en) 2007-10-26 2014-10-21 Cyberonics, Inc. Dynamic lead condition detection for an implantable medical device
US8942798B2 (en) 2007-10-26 2015-01-27 Cyberonics, Inc. Alternative operation mode for an implantable medical device based upon lead condition
US9402991B1 (en) 2008-01-24 2016-08-02 Advanced Bionics, Llc Microcircuit cochlear electrode array and method of manufacture
US8897894B1 (en) 2008-01-24 2014-11-25 Advanced Bionics Llc Microcircuit cochlear electrode array and method of manufacture
US8250745B1 (en) 2008-01-24 2012-08-28 Advanced Bionics, Llc Process for manufacturing a microcircuit cochlear electrode array
US9314633B2 (en) 2008-01-25 2016-04-19 Cyberonics, Inc. Contingent cardio-protection for epilepsy patients
US8204603B2 (en) 2008-04-25 2012-06-19 Cyberonics, Inc. Blocking exogenous action potentials by an implantable medical device
US8457747B2 (en) 2008-10-20 2013-06-04 Cyberonics, Inc. Neurostimulation with signal duration determined by a cardiac cycle
US20100100151A1 (en) * 2008-10-20 2010-04-22 Terry Jr Reese S Neurostimulation with signal duration determined by a cardiac cycle
US8874218B2 (en) 2008-10-20 2014-10-28 Cyberonics, Inc. Neurostimulation with signal duration determined by a cardiac cycle
US10653883B2 (en) 2009-01-23 2020-05-19 Livanova Usa, Inc. Implantable medical device for providing chronic condition therapy and acute condition therapy using vagus nerve stimulation
US20100299921A1 (en) * 2009-05-26 2010-12-02 Hall Peter C Cable Consolidation with a Laser
US8850702B2 (en) * 2009-05-26 2014-10-07 Cardiac Pacemakers, Inc. Cable consolidation with a laser
US8332052B1 (en) 2010-03-18 2012-12-11 Advanced Bionics Microcircuit cochlear electrode array and method of manufacture
US8849426B1 (en) 2010-03-18 2014-09-30 Advanced Bionics Ag Microcircuit cochlear electrode array and method of manufacture
US8478428B2 (en) 2010-04-23 2013-07-02 Cyberonics, Inc. Helical electrode for nerve stimulation
US20200054229A1 (en) * 2014-10-31 2020-02-20 Board Of Regents Of The University Of Texas System Method of making a neural interface system
WO2018157210A1 (en) * 2017-03-02 2018-09-07 Saluda Medical Pty Limited Printed lead

Also Published As

Publication number Publication date
ATE519520T1 (en) 2011-08-15
US6843870B1 (en) 2005-01-18
EP1651305B1 (en) 2011-08-10
CA2533215A1 (en) 2005-01-27
EP1651305A1 (en) 2006-05-03
WO2005007235A1 (en) 2005-01-27
US20050016657A1 (en) 2005-01-27
CA2533215C (en) 2012-05-29

Similar Documents

Publication Publication Date Title
US6843870B1 (en) Implantable electrical cable and method of making
US11103694B2 (en) Cardiac or cerebral vessel microlead with electrode ring
US5330520A (en) Implantable electrode and sensor lead apparatus
US5554176A (en) Implantable electrode and sensor lead apparatus
US4573481A (en) Implantable electrode array
EP3532150B1 (en) Nerve cuff electrodes fabricated using over-molded lcp substrates
US5458629A (en) Implantable lead ring electrode and method of making
US9844661B2 (en) Compliant electrical stimulation leads and methods of fabrication
US5324321A (en) Medical electrical lead having sigmoidal conductors and non-circular lumens
US5957970A (en) Method of fabricating a medical electrical lead
JP3447737B2 (en) Electrophysiological lead for implants
JP4452724B2 (en) Stretched strand-filled tube wire
CA2116188C (en) Metallized implantable cardiac electrode
JP5180087B2 (en) Implantable electrophysiology lead body
US8150533B2 (en) Medical lead and method for medical lead manufacture
US20040111139A1 (en) Apparatus and methods for differential stimulation of nerve fibers
US7065411B2 (en) Electrical medical leads employing conductive aerogel
US20050027341A1 (en) System and method for providing a medical lead body having conductors that are wound in opposite directions
JPS6111115B2 (en)
US8250754B2 (en) Method of manufacturing a medical electrical lead with insert-molded electrode
JPH11504543A (en) Medical lead having a compression lumen
JP2008538997A (en) Medical electrode with conductive polymer
WO2007128001A2 (en) Methods of making implantable medical leads with a non-linear shape
EP0027465A1 (en) Long-life flexible electrode lead
US20080269860A1 (en) Methods of making implantable medical leads with a non-linear shape

Legal Events

Date Code Title Description
AS Assignment

Owner name: MED-EL ELEKTRO-MEDIZINISCHE GERATE GESELLSCHAFT M.

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:EPIC BIOSONICS INC.;REEL/FRAME:019102/0276

Effective date: 20061227

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION